FDA Grants Approval for Lorazepam ANDA200542 by Rising
The FDA has granted approval for the ANDA200542 application for Lorazepam submitted by Rising.
Asset / Drug
Drug and asset intelligence for Lorazepam with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.